3min chapter

Inside the Strategy Room cover image

159. Voices of CEO Excellence: Merck’s Ken Frazier. Episode 1

Inside the Strategy Room

CHAPTER

The Importance of R&D in Pharmaceutical CEOs

A Wall Street analyst report said pharmaceutical CEOs should stop investing in R&D and invest in non-farma assets. Merck had five-year earnings guidance, which only two of those five years had elapsed when I took over. "I felt very strongly that if Merck was going to be an R&D focus company, this was the moment of truth for us," he says.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode